Q2 FY2026 EarningsQ2 FY26 results were mixed relative to consensus: revenue of $487.8M slightly beat expectations of $478.0M (+2.05% variance), while GAAP EPS of $0.49 missed the $0.52 mean estimate. Despite a 2.1% YoY decline in same-unit patient volume, revenue growth was supported by improved reimbursement metrics and a 135 bps increase in commercial payor mix. Adjusted EPS of $0.63 exceeded the normalized consensus of $0.59. Management reaffirmed FY26 Adjusted EBITDA guidance of $280M-$300M, consistent with market expectations.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Pediatrix Medical(MD) the Revenue is 487.78 M (+4.04%), Beat estimate;the EBIT is 70.65 M (+4%), Beat estimate;the EPS is 0.49 (+6.52%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.49B4.04%
0.48B1.95%
+0.01B2.09%
EBITExceed expectations
0.07B4.00%
0.07B2.51%
+0.00B6.51%
EPSMiss expectations
0.496.52%
0.52413.92%
-0.03407.40%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf